Also trades as: BIOC (NASDAQ) · $vol 1M
BIOCQ OTC
Biocept, Inc.
1W: -0.0%
1M: +100.0%
3M: -0.0%
YTD: +100.0%
1Y: +100.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$13M
-460.1% ▼
Capital Expenditures
$807K
+48.7% ▲
3Y CAGR: +3.2%
Free Cash Flow
-$14M
-765.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$16M
-210.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$25M | -$18M | -$3M | -$32M |
| Depreciation & Amort. | $773K | $1M | $3M | $2M |
| Stock-Based Comp. | $870K | $941K | $2M | $3M |
| Change in Working Capital | -$1M | -$6M | $1M | $13M |
| Other Non-Cash Items | $2M | $2M | $111K | $631K |
| Operating Cash Flow | -$23M | -$20M | $4M | -$13M |
| — Investing Activities — | ||||
| Capital Expenditures | -$735K | -$867K | -$2M | -$807K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$735K | -$867K | -$2M | -$807K |
| — Financing Activities — | ||||
| Net Debt Issuance | -$933K | -$2M | -$1M | -$1M |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $5M | $0 | -$622K | -$806K |
| Financing Cash Flow | $30M | $26M | $12M | -$2M |
| Net Change in Cash | $6M | $5M | $14M | -$16M |
| Cash End of Period | $9M | $14M | $29M | $13M |
| Free Cash Flow | -$24M | -$21M | $2M | -$14M |